The right direction of the diagnostic power assessment is a combined analysis of the tested parameters, which was demonstrated also in our previous studies on other cytokines (M-CSF, VEGF) in breast cancer patients [41, 42]. The gene discussed is VEGFA; the disease is breast cancer.